|
FY2012
12 months to Dec 31, 2012
|
FY2011
12 months to Dec 31, 2011
|
|
|---|---|---|
| Net income (loss) | ||
| Cash flows from operating activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Non-cash share-based compensation expense | ||
| Non-cash asset impairments | ||
| Non-cash interest expense | ||
| Non-cash charge for contingent consideration | ||
| Non-cash charge for option amortization | ||
| Deferred tax provision | ||
| Depreciation and amortization expense | ||
| Other, net | ||
| Changes in assets and liabilities, net of businesses acquired: | ||
| Accounts receivable | ||
| Inventory | ||
| Prepaid expenses and other current assets | ||
| Prepaid income taxes and income taxes payable | ||
| Other assets | ||
| Accounts payable | ||
| Accrued expenses and other current liabilities | ||
| Payment of contingent consideration | ||
| Other non-current liabilities | ||
| Net cash provided by operating activities | ||
| Net cash provided by operating activities | ||
| Cash flows from investing activities: | ||
| Purchase of Lev Pharmaceuticals, Inc. | ||
| Purchase of DuoCort Pharma AB, net of cash acquired | ||
| DuoCort Pharma AB | ||
| Total purchase of DuoCort Pharma AB, net of cash acquired | ||
| Payment for option purchase right | ||
| Purchase of Vancocin assets | ||
| Purchase of property, equipment and building improvements | ||
| Purchase of investments | ||
| Maturities of investments | ||
| Purchase of short-term investments | ||
| Maturities and sales of short-term investments | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Payment for treasury shares acquired | ||
| Repayment of debt | ||
| Payment of financing costs | ||
| Payment of contingent consideration | ||
| Net proceeds from issuance of common stock | ||
| Excess tax benefits from share-based payment arrangements | ||
| Net cash provided (used in) by financing activities | ||
| Effect of exchange rate changes on cash | ||
| Net (decrease) increase in cash and cash equivalents | ||
| Net cash (used in) provided by financing activities | ||
| Effect of exchange rate changes on cash | ||
| Net (decrease) increase in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of year | ||
| Cash and cash equivalents at end of year |
Loading...
